Promote Sponsor
verified SJR 5,507 · Q1 • database Scopus / SJR & Web of Science indexed
Nature Reviews Rheumatology
United Kingdom · Nature Research
workspace_premium Q1 — Rheumatology lock Subscription Unclaimed

Nature Reviews Rheumatology

Nature Reviews Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 198. It has an SJR impact factor of 5,507 and it has a best quartile of Q1. It has an SJR impact factor of 5,507.

Nature Reviews Rheumatology focuses its scope in these topics and keywords: linked, developed, ra, criteria, imprinted, diabetes, lossduality, fibroblastlike, classification, cardiovascular, ...

ISSN: 1759-4790
Editorial: Nature Research
Category: Rheumatology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD Subscribe
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
5,507 Q1
H-index 198
Tasa de Aceptación pie_chart
21% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

5,507

H-index

198

Docs (year)

130

Docs 3y

502

Total refs

7733

Cites 3y

4716

Citable 3y

256

Cites/Doc 2y

9.64

Ref/Doc

59.48

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bone balance restored by blocking Dickkopf-1 in a mouse model of inflammatory arthritis

View more

What is the evidence for valgus bracing effects in knee OA?

View more

Dermal white adipose tissue implicated in SSc pathogenesis

View more

Deficient antigen-specific T cell responses in SLE-prone mice

View more

CRP gene variants complicate diagnosis and treatment of inflammatory conditions

View more

Could IL-23 go solo as a therapeutic target for psoriasis?

View more

Could early biologics prevent disease?

View more

Conservative biomechanical strategies for knee osteoarthritis

View more

Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens

View more

Classifying RA the 2010 way - what does it mean for the clinic?

View more

Chondrocyte protection - SIRTified?

View more

Choline kinase - more than a cancer therapy target?

View more
SHOW MORE ARTICLES

Bone-healing effects of denosumab in RA

View more

'Treat-to-target' with allopurinol is feasible in patients with gout

View more

Blood coagulation factor drives arthritis pathogenesis

View more

B cell checkpoints in autoimmune rheumatic diseases

View more

Are calcium phosphate ceramics 'smart' biomaterials?

View more

Approaches to the targeting of treatment for osteoporosis

View more

Anti-inflammatory hope for AIN457

View more

Another cog in the mechanism of methotrexate

View more

AMPK: a therapeutic target in RA?

View more

Alternative pathways of osteoclastogenesis in inflammatory arthritis

View more

Abatacept for treating ACPA-negative UA?

View more

A nose for cartilage repair

View more

FAQS